Platelet-derived growth factor (PDGF): Actions and mechanisms in vascular smooth muscle

General Pharmacology

Volumn 27, Issue 7, 1996, Pages 1079-1089

  Hughes, A D ^a   Clunn, G F ^a   Refson, J ^a   Demoliou Mason, C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

chemotaxis; excitation contraction coupling; migration; pathophysiology; platelet derived growth factor; proliferation; signal transduction; vascular smooth muscle cell

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3 [1 (3 AMINOPROPYL) 3 INDOLYL] 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; CALCIUM; CATION; GLYCOPROTEIN; MEPACRINE; NORDIHYDROGUAIARETIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; RAS PROTEIN;

ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HYDROPHILICITY; MACROPHAGE; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; THROMBOCYTE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSELS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR;

EID: 0030273271     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00060-2     Document Type: Review

References (189)

1. Abedi H., Dawes K. E. and Zachary I. (1995) Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J. Biol. Chem. 270, 11367-11376.
2. Abedi H. and Zachary I. (1995) Signaling mechanism in the regulation of vascular cell migration. Cardiovasc. Res. 30, 544-556.
3. Albelda S. M. and Buck C. A. (1990) Integrins and other cell adhesion molecules. FASEB J. 4, 2868-2880.
4. Amento E. P., Ehsani N., Palmer H. and Libby P. (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11, 1223-1230.
5. Arvidsson A. K., Rupp E., Nanberg E., Downward J., Ronnstrand L., Wennstrom S., Schlessinger J., Heldin C. and Claesson-Welsh L. (1994) Tyr-716 in the platelet-derived growth factor β-receptor kinase insert is involved in GRB2 binding and ras activation. Mol. Cell Biol. 14, 6715-6726.
6. Bar Sagi D., Rotin D., Batzer A., Mandiyan V. and Schlessinger J. (1993) SH3 domains direct cellular localization of signaling molecules. Cell 74, 83-91.
7. Barrett T. B. and Benditt E. P. (1988) Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. U.S.A. 85, 2810-2814.
8. Battegay E. J., Raines E. W., Seifert R. A., Bowen Pope D. F. and Ross R. (1990) TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63, 515-524.
9. Benjamin C. W. and Jones D. A. (1994) Platelet-derived growth factor stimulates growth factor receptor binding protein-2 association with Shc in vascular smooth muscle cells. J. Biol. Chem. 269, 30911-30916.
10. Bennett M. R., Evan G. I. and Schwartz S. M. (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95, 2266-2274.
11. Berk B. C., Alexander R. W., Brock T. A., Gimbrone M. A. Jr. and Webb R. C. (1986) Vasoconstriction: a new activity for platelet-derived growth factor. Science 232, 87-90.
12. Berk B. C. and Alexander R. W. (1989) Vasoactive effects of growth factors. Biochem. Pharmacol. 38, 219-225.
13. Berk B. C. and Rao G. N. (1993) Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J. Cell Physiol. 154, 368-380.
14. Berra E., Diaz Meco M. T., Dominguez I., Municio M. M., Sanz L., Lozano J., Chapkin R. S. and Moscat J. (1993) Protein kinase C zeta isoform is critical for mitogenic signal transjuction. Cell 74, 555-563.
15. Betsholtz C., Johnsson A., Heldin C. H., Westermark B., Lind P., Urdea M.S., Eddy R., Shows T. B., Philpott K., Mellor A. L. et al. (1986) cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320, 695-699.
16. Bilato C., Pauly R. R., Melillo G., Monticone R., Gorelick-Feldman D., Gluzband Y. A., Sollott S. J., Ziman B., Lakatta E. G. and Crow M. T. (1995) Intracellular signaling pathways required for rat vascular smooth muscle cell migration. J. Clin. Invest. 96, 1905-1915.
17. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 86, 2388-2392.
18. Bonthron D. T., Morton C. C., Orkin S. H. and Collins T. (1988) Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 85, 1492-1496.
19. Bornfeldt K. E., Raines E. W., Nakano T., Graves L. M., Krebs E. G. and Ross R. (1994) Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93, 1266-1274.
20. Bourne H. R., Sanders D. A. and McCormick F. (1990) The GTPase superfamily: conserved switch for diverse cell functions. Nature 348, 125-132.
21. Bourne H. R., Sanders D. A. and McCormick F. (1991) The GTPase superfamily: conserved structure and molecular mechanism. Nature 349, 117-127.
22. Bowen Pope D. F., Hart C. E. and Seifert R. A. (1989) Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which hind to different classes of PDGF receptor. J. Biol. Chem. 264, 2502-2508.
23. Bowen Pope D. F. and Ross R. (1982) Platelet-derived growth factor. II. Specific binding to cultured cells. J. Biol. Chem. 257, 5161-5171.
24. Case R. D., Piccione E., Wolf G., Benett A. M., Lechleider R. J., Neel B. G. and Shoelson S. E. (1994) SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J. Biol. Chem. 269, 10467-10474.
25. Casey P. J. (1995) Protein lipidation in cell signaling. Science 268, 221-225.
26. Chamley Campbell J., Campbell G. R. and Ross R. (1979) The smooth muscle cell in culture. Physiol. Rev. 59, 1-61.
27. Chung J., Grammer T. C., Lemon K. P., Kazlauskas A. and Blenis J. (1994) PDGF-and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71-75.
28. Claesson Welsh L., Eriksson A., Westermark B. and Heldin C. H. (1989a) cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc. Natl. Acad. Sci. U.S.A. 86, 4917-4921.
29. Claesson Welsh L., Hammacher A., Westermark B., Heldin C. H. and Nister M. (1989b) Identification and structural analysis of the A type receptor for platelet-derived growth factor. Similarities with the B type receptor. J. Biol. Chem. 264, 1742-1747.
30. Claesson-Welsh L. (1994) Platelet-derived growth factor receptor signals. J. Biol. Chem. 269, 32023-32026.
31. Clark E. A. and Brugge J. S. (1995) Integrins and signal transduction pathways: the road taken. Science 268, 233-239.
32. Clunn G. F., Refson J. R., Schachter M. and Hughes A. D. (1995) Different effects of platelet derived growth factor isoforms on DNA synthesis and migration in human vascular smooth muscle cells. Biochem. Soc. Trans. (in press).
33. Collins T., Pober J. S., Gimbrone M. A. Jr., Hammacher A., Betsholtz C., Westermark B. and Heldin C. H. (1987) Cultured human endothelial cells express platelet-derived growth factor A chain. Am. J. Pathol. 126, 7-12.
34. Cooper J. A. (1991) The role of actin polymerization in cell motility. Annu. Rev. Physiol. 53, 585-605.
35. Corjay M. H., Thompson M. M., Lynch K. R. and Owens G. K. (1989) Differential effect of platelet-derived growth factor-versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. J. Biol. Chem. 264, 10501-10506.
36. Dekker L. V. and Parker P. J. (1994) Protein kinase C - a question of specificity. T. I. B. S. 19, 73-77.
37. Diliberto P. A., Gordon G. and Herman B. (1991a) Regional and mechanistic differences in platelet-derived growth factor-isoform-induced alterations in cytosolic free calcium in porcine vascular smooth muscle cells. J. Biol. Chem. 266, 12612-12617.
38. Diliberto P. A., Hubbert T. and Herman B. (1991b) Early PDGF-induced alterations in cytosolic free calcium are required for mitogenesis. Res. Commun. Chem. Pathol. Pharmacol. 72, 3-12.
39. Doolittle R. F., Hunkapiller M. W., Hood L. E., Devare S. G., Robbins K. C., Aaronson S. A. and Antoniades H. N. (1983) Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221, 275-277.
40. Drozdoff V. and Pledger W. J. (1991) Cellular response to platelet-derived growth factor (PDGF)-AB after down-regulation of PDGF alpha-receptors. Evidence that functional binding does not require alpha-receptors. J. Biol. Chem. 266, 17165-17172.
41. Eriksson A., Siegbahn A., Westermark B., Heldin C. H. and Claesson Welsh L. (1992) PDGF alpha-and beta-receptors activate unique and common signal transduction pathways. EMBO J. 11, 543-550.
42. Eriksson A., Nanberg E., Ronnstrand L., Engstrom U., Hellman U., Rupp E., Carpenter G., Heldin C. H. and Claesson Welsh L. (1995) Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors. J. Biol. Chem. 270, 7773-7781.
43. Fantl W. J., Escohedo J. A., Martin G. A., Turck C. W., Del Rosario M., McCormick F. and Williams L. T. (1992) Distinct phosphotyrosines on a growth factot receptor hind to specific molecules that mediate different signaling pathways. Cell 69, 413-423.
44. Ferns G. A., Sprugel K. H., Seifert R. A. and Bowen-Pope D. F. (1990) Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF. Growth Factors 3, 315-324.
45. Freidman R. J., Stemerman M. B. and Wenz B. (1977) The effect of thrombocytopaenia on experimental arteriosclerosis lesion formation in rabbits: smooth muscle cell proliferation and reendothelialization. J. Clin. Invest. 60, 1191-1201.
46. Fukami K., Furuhashi K., Inagaki M., Endo T., Hatano S. and Takenawa T. (1992) Requirement of phosphatidylinositol 4,5-bisphosphate for α-actinin function. Nature 359, 150-152.
47. Glagov S., Weisenberg E., Zarins C. K., Stankunavicius R. and Kolettis G. J. (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316, 1371-1375.
48. Hart C. E., Forstrom J. W., Kelly J. D., Seifert R. A., Smith R. A., Ross R., Murray M. J. and Bowen-Pope D. F. (1988) Two classes of PDGF receptor recognise different isoforms of PDGF. Science 240, 1529-1531.
49. Heldin C. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
50. Heldin C. H., Wasteson A. and Westermark B. (1982) Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation. J. Biol. Chem. 257, 4216-4221.
51. Heldin C. H., Backstrom G., Ostman A., Hammacher A., Ronnstrand L., Rubin K., Nister M. and Westermark B. (1988) Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J. 7, 1387-1393.
52. Hidaka Y., Eda T., Yonemoto M. and Kamei T. (1992) Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Atherosclerosis 95, 87-94.
53. Homma Y., Sakamoto H., Tsunoda M., Aoki M., Takenawa T. and Ooyama T. (1993) Evidence for involvement of phospholipase C-gamma 2 in signal transduction of platelet-derived growth factor in vascular smooth muscle cells. Biochem. J. 290, 649-653.
54. 2- entry is blocked by antibodies to phosphatidylinositol 4,5-bisphosphate but does not involve heparin-sensitive inositol 1,4,5-trisphosphate receptors. J. Biol. Chem. 266, 4045-4048.
55. 2- in rabbit isolated ear artery by platelet-derived growth factor. Br. J. Pharmacol. 114, 138-142.
56. Hughes A. D. (1995b) Calcium channels in vascular smooth muscle cells. J. Vasc. Res. 32, 353-370.
57. Hughes A. D., Patel M., Wijetunge S., Clunn G. and Schachter M. (1995) Comparison of the effects of platelet-derived growth factor isoforms on signaling and DNA synthesis of human cultured saphenous vein cells. J. Cardiovasc. Pharmacol. 25, 481-485.
58. Hughes A. D. and Schachter M. (1994) Hypertension and blood vessels. Br. Med Bull. 50, 356-370.
59. Indolfi C., Avvedimento E. V., Rapacciuolo A. and Di Lorenzo E. (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Medicine 1, 541-545.
60. Inui H., Kitami Y., Kondo T. and Inagami T. (1993) Transduction of mitogenic activity of platelet-derived growth factor (PDGF) AB by PDGF-β receptor without participation of PDGF-α receptor in vascular smooth muscle cells. J. Biol. Chem. 268, 17045-17050.
61. Inui H., Kitami Y., Tani M., Kondo T. and Inagami T. (1994a) Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. J. Biol. Chem. 269, 30546-30552.
62. Inui H., Kondo T., Konishi F., Kitami Y. and Inagami T. (1994b) Participation of diacylglycerol kinase in mitogenic signal transduction induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 205, 1338-1344.
63. Irani K., Herzlinger S. and Finkel T. (1994) Ras proteins regulate multiple mitogenic pathways in A10 vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 202, 1252-1258.
64. 2+ exchanger. J. Biol. Chem. 270, 8996-9001.
65. Kapeller R. and Cantley L. C. (1994) Phosphatidylinositol 3-kinase. Bioessays 16, 565-576.
66. Kariya K., Kawahara Y., Tsuda T., Fukuzaki H. and Takai Y. (1987) Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis 63, 251-255.
67. Karlsson T., Songyang Z., Landgren E., Lavergne C., Di-Fiore P. P., Anafi M., Pawson T., Cantley L. C., Claesson-Welsh L. and Welsh M. (1995) Molecular interactions of the Src homology 2 domain proteins Shb with phosphotytosine residues, tyrosine kinase teceptors and Src homology 3 domain proteins. Oncogens 10, 1475-1485.
68. Keating M. T. and Williams L. T. (1987) Processing of the platelet-derived growth factor receptor. Biosynthetic and degradation studies using antireceptor antibodies. J. Biol. Chem. 262, 7932-7937.
69. Kelly J. D., Haldeman B. A., Grant F. J., Murray M. J., Seifert R. A., Bowen Pope D. F., Cooper J. A. and Kazlauskas A. (1991) Platelet-derived growth factor (PDGF) stimulates PDGF receptot subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem. 266, 8987-8992.
70. Kemp P. R., Shachar Hill Y., Weissberg P. L. and Metcalfe J. C. (1993) Inhibition of PDGF BB stimulated DNA synthesis in rat aortic vascular smooth muscle cells by the expression of a truncated PDGF beta receptor. FEBS Lett. 336, 119-123.
71. Khachigian L. M. and Chesterman C. N. (1992) Platelet-derived growth factor and alternative splicing: a review. Pathology 24, 280-290.
72. Khalil R. A., Menice C. B., Wang C. A. and Morgan K. G. (1995) Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ. Res. 76, 1101-1108.
73. Khalil R. A. and Morgan K. G. (1993) PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am. J. Physiol. 265, C406-11.
74. Kihara M., Robinson P. J., Buck S. H. and Dage R. C. (1989) Mitogensis by serum and PDGF is independent of PI degradation and PKC in VSMC. Am. J. Physiol. 256, C886-C892.
75. Ko Y., Totzke G., Graack G. H., Heidgen F. J., Meyer zu Brickwedde M. K., Dusing R., Vetter H. and Sachinidis A. (1993) Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J. Hypertens. 11, 1171-1178.
76. Ko Y. D., Sachinidis A., Graack G. H., Appenheimer M., Wieczorek A. J., Dusing R. and Vetter H. (1992) Inhibition of angiorensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers. Clin. Investig. 70, 113-117.
77. 2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. J. Biol. Chem. 269, 9011-9018.
78. Kohler N. and Lipton A. (1974) Platelets as a source of fibroblast growth-promoting activity. Exp. Cell Res. 87, 297-301.
79. Kondo T., Inui H., Konishi F. and Inagami T. (1992) Phospholipase D mimics platelet-derived growth factor as a competence factor in vascular smooth muscle cells. J. Biol. Chem. 267, 23609-23616.
80. Kondo T., Konishi F., Inui H. and Inagami T. (1993) Differing signal transductions elicited by three isoforms of platelet-detived growth factor in vascular smooth muscle cells. J. Biol. Chem. 268, 4458-4464.
81. Kovalenko M., Gazit A., Bohmer A., Rorsman C., Ronnstrand L., Heldin C. H., Waltenberger J., Bohmer F. D. and Levitzki A. (1994) Selective platelet-derived growth factor receptor kinase hlockers reverse sis-transformation. Cancer Res. 54, 6106-6114.
82. Koyama N., Morisaki N., Saito Y. and Yoshida S. (1992) Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J. Biol. Chem. 267, 22806-22812.
83. Koyama N., Hart C. E. and Clowes A. W. (1994) Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ. Res. 75, 682-691.
84. Kundra V., Escobedo J. A., Kazlauskas A., Kim H. K., Rhee S. G., Williams L. T. and Zetter B. R. (1994) Regulation of chemotaxis by the platelet-derived growth factor receptor-b. Nature 367, 474-476.
85. Kundra V., Anand-Apte B., Feig L. and Zetter B. R. (1995) The chemotactic response to PDGF-BB: evidence of a role for ras. J. Cell Biol. 130, 725-731.
86. LaFleur D. W., Fagin J. A., Forrester J. S., Rubin S. A. and Sharifi B. G. (1994) Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells. J. Biol. Chem. 269, 20757-20763.
87. Levitzki A. and Gazit A. (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788.
88. Libby P., Warner S. J., Salomon R. N. and Birinyi L. K. (1988) Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma. N. Engl. J. Med. 318, 1493-1498.
89. Liscovitch M. and Cantley L. C. (1994) Lipid second messengers. Cell 77, 329-334.
90. + exchange by platelet-derived growth factor involves phosphatidylinositol 3′-kinase and phospholipase C gamma. J. Biol. Chem. 269, 30734-30739.
91. Majack R. A., Cook S. C. and Bornstein P. (1985) Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J. Cell Biol. 101, 1059-1070.
92. Majack R. A., Majesky M. W. and Goodman L. V. (1990) Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J. Cell Biol. 111, 239-247.
93. Majesky M. W., Daemen M. J. and Schwartz S. M. (1990a) Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J. Biol. Chem. 265, 1082-1088.
94. Majesky M. W., Reidy M. A., Bowen Pope D. F., Hart C. E., Wilcox J. N. and Schwartz S. M. (1990b) PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol. 111, 2149-2158.
95. Majesky M. W. and Schwartz S. M. (1990) Smooth muscle diversity in arterial wound repair. Toxicol. Pathol. 18, 554-559.
96. +)-induced Ca2+ release channels. Circ. Res. 69, 1327-1339.
97. Matuoka K., Shibasaki F., Shibata M. and Takenawa T. (1993) Ash/Grb-2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 12, 3467-3473.
98. Miano J. M., Vlasic N., Tota R. R. and Stemermen M. B. (1993) Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth. Arterioscler. Thromb. 13, 211-219.
99. Mogami H. and Kojima I. (1993) Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 196, 650-658.
100. Morgan K. G., DeFeo T. T., Wenc K. and Weinstein R. (1985) Alterations of excitation-contraction coupling by platelet-derived growth factor in enzymatically isolated and cultured vascular smooth muscle cells. Pflugers Arch. 405, 77-79.
101. Morisaki N., Takahashi K., Shiina R., Zenibayashi M., Otabe M., Yoshida S. and Saito Y. (1994) Platelet-derived growth factor is a potent stimulator of expression of intercellular adhesion molecule-1 in human arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 200, 612-618.
102. Mulcahy L. S., Smith M. R. and Stacey D. W. (1985) Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313, 241-243.
103. Munro E., Patel M., Chan P., Betteridge L., Clunn G., Gallagher K., Hughes A., Schachter M., Wolfe J. and Sever P. (1994) Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Eur. J. Clin. Invest. 24, 766-772.
104. Nakahara K., Nishimura H., Kuro O., Takewaki S., Iwase M., Ohkubo A., Yazaki Y. and Nagai R. (1992) Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem. Biophys. Res. Commun. 184, 811-818.
105. Nakano T., Raines E. W., Abraham J. A., Wenzel F. G. 4th, Higashiyama S., Klagsbrun M. and Ross R. (1993) Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. J. Biol. Chem. 268, 22941-22947.
106. Nakao J., Ooyama T., Ito H., Chang W. C. and Murota S. (1982) Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration. Atherosclerosis 44, 339-342.
107. Nakao J., Ito H., Chang W. C., Koshihara Y. and Murota S. (1983) Aortic smooth muscle cell migration caused by platelet-derived growth factor is mediated by lipoxygenase product(s) of arachidonic acid. Biochem. Biophys. Res. Commun. 112, 866-871.
108. Nakao J., Ito H., Koshihara Y., Chang W. C. and Murota S. (1985) Mode of action of aortic smooth-muscle cell migration induced by 12-L-hydroxy5,8,10,14-eicosatetraenoic acid and platelet-derived growth factor. Adv. Prostaglandin Thromboxane Leukot. Res. 15, 681-683.
109. Newby A. C., Lim K., Evans M. A., Brindle N. P. and Booth R.F. (1995) Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br. J. Pharmacol. 114, 1652-1656.
110. Nobes C., Hawkins P. T., Stephens L. and Hall A. (1995) Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J. Cell Sci. 108, 225-233.
111. Nomoto A., Mutoh S., Hiroyuki H. and Yamaguchi I. (1988) Smooth muscle cell migration induced by inflammatory cell products and its inhibtion by a potent calcium antagonist, nilvadipine. Atherosclerosis 72, 213-219.
112. O'Brien E. R. and Schwartz S. M. (1994) Update on the biology and clinical study of restenosis. Trends Cardiovasc. Med. 4, 169-178.
113. 2+ kinetics in cultured rat vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 17 Suppl 7, S124-6.
114. Okada Y., Katsuda S., Matsui Y. and Nakanishi I. (1992) The modulation of collagen synthesis in cultured arterial smooth muscle cells by platelet-derived growth factor. Cell Biol. Int. Rep. 16, 1015-1022.
115. Okada Y., Katsuda S., Watanabe H. and Nakanishi I. (1993) Collagen synthesis of human arterial smooth muscle cells: effects of platelet-derived growth factor, transforming growth factor-beta 1 and interleukin-1. Acta Pathol. Jpn. 43, 160-167.
116. Okazaki H., Majesky M. W., Harker L. A. and Schwartz S. M. (1992) Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ. Res. 71, 1285-1293.
117. Olson M. F., Ashworth A. and Hall A. (1995) An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269, 1270-1272.
118. Owen N. E. (1984) Platelet-derived growth factor stimulates Na+ influx in vascular smooth muscle cells. Am. J. Physiol. 247, 501-505.
119. Owens G. K. (1995) Regulation of differentiation of vascular smooth muscle cells. Pharmacol. Rev. 75, 487-517.
120. Ozaki Y., Ohashi T. and Niwa Y. (1986) A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem. Pharmacol. 35, 3481-3488.
121. Pauly R. R., Bilato C., Sollott S. J., Monticone R., Kelly P. T., Lakatta E. G. and Crow M. T. (1995) Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation 91, 1107-1115.
122. Pawson T. and Gish G. D. (1992) SH2 and SH3 domains: from structure to function. Cell 71, 359-362.
123. Pekny M., Ostman A., Hermansson A., Nister M., Heldin C. H. and Westermark B. (1994) Differences in binding to the solid substratum and extracellular matrix may explain isoform-speciflc paracrine effects of platelet-derived growth factor. Growth Factors 10, 77-87.
124. Pertile P., Liscovitch M., Chalifa V. and Cantley L. C. (1995) Phosphatidylinositol 4,5-bisphosphate synthesis is required for activation of phospholipase D in U937 cells. J. Biol. Chem. 270, 5130-5135.
125. Raines E. W., Dower S. K. and Ross R. (1989) Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243, 393-396.
126. Rao G. N., Corson M. A. and Berk B. C. (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J. Biol. Chem. 266, 8604-8608.
127. Richardson A. and Parsons J. T. (1995) Signal transduction throughh integrins: a central role for focal adhesion kinase? Bioessays 17, 229-236.
128. Ridley A. J., Paterson H. F., Johnston C. L., Diekmann D. and Hall A. (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70, 401-410.
129. Ridley A. J. and Hall A. (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399.
130. Rodriguea-Viciana P., Warne P. H., Dhand R., Vanhaesebroeck B., Gout I., Fry M., Waterfield M. D. and Downward J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
131. Rorsman F., Bywater M., Knott T. J., Scott J. and Betsholtz C. (1988) Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins. Mol. Cell Biol. 8, 571-577.
132. Rorsman F. and Betsholtz C. (1992) Characterization of the mouse PDGF A-chain gene. Evolutionary conservation of gene structure, nucleotide sequence and alternative splicing. Growth Factors 6, 303-313.
133. Ross R., Glomset J. A., Kariya B. and Harker L. (1974) A platelet-dependent serum factot that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 71, 1207-1210.
134. Ross R., Raines E. and Bowen Pope D. (1982) Growth factors from platelets, monocytes, and endothelium: their role in cell proliferation. Ann. N. Y. Acad. Sci. 397, 18-24.
135. Ross R. (1986) The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314, 488-500.
136. Ross R., Raines E. W. and Bowen Pope D. F. (1986) The biology of platelet-derived growth factor. Cell 46, 155-169.
137. Ross R. (1989) Platelet-derived gtowth factor. Lancet 1, 1179-1182.
138. Ross R., Bowen Pope D. F. and Raines E. W. (1990) Platelet-derived growth factor and its role in health and disease. Philos. Trans. R. Soc. Lond. Biol. 327, 155-169.
139. Ross R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
140. Rothman A., Wolner B., Button D. and Taylor P. (1994) Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. J. Biol. Chem. 269, 6399-6404.
141. Rozakis Adcock M., Fernley R., Wade J., Pawson T. and Bowtell D. (1993) The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363, 83-85.
142. Rupp E., Siegbahn A., Ronnstrand L., Wernstedt C., Claesson Welsh L. and Heldin C. H. (1994) A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a hetetodimeric receptor complex. Eur. J. Biochem. 225, 29-41.
143. Sachinidis A., Locher R., Hoppe J. and Vetter W. (1990a) The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett. 275, 95-98.
144. Sachinidis A., Locher R., Vetter W., Tarje D. and Hoppe J. (1990b) Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J. Biol. Chem. 265, 10238-10243.
145. Sachinidis A., Schulte K., Ko Y., Meyer zu Brickwedde M. K., Hoppe V., Hoppe J. and Vetter H. (1993) The induction of early response genes in rat smooth muscle cells by PDGF-AA is not sufficient to stimulate DNA-synthesis. FEBS Lett. 319, 221-224.
146. Sasaguri T., Kosaka C., Hirata M., Masuda J., Shimokado K., Fujishima M. and Ogata J. (1993) Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate G1/S inhibition. Exp. Cell Res. 208, 311-320.
147. Sato Y., Hamanaka R., Ono J., Kuwan M., Rifkin D. B. and Takaki R. (1991) The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. Biochem. Biophys. Res. Commun. 1260, 1266.
148. 2+)-responsiveness of smooth muscle contraction. FEBS Lett. 324, 211-215.
149. Satoh T., Fantl W. J., Escobedo J. A., Williams L. T. and Kaziro Y. (1993) Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types. Mol. Cell Biol. 13, 3706-3713.
150. Sauro M. D. and Thomas B. (1993) Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibtion of protein tyrosine kinase(s). J.Pharmacol.Exp.Ther. 267, 1119-1125.
151. Schollmann C., Grugel R., Tatje D., Hoppe J., Folkman J., Marme D. and Weich H. A. (1992) Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isotorms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells. J. Biol. Chem. 267, 18032-18039.
152. Schonherr E., Jarvelainen H. T., Sandell L. J. and Wight T. N. (1991) Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266, 17640-17647.
153. Schonherr E., Jarvelainen H. T., Kinsella M. G., Sandell L. J. and Wight T. N. (1993) Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of highlycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb. 13, 1026-1036.
154. Sgaragli G. P., Valoti M., Gorelli B., Fusi F., Palmi M. and Mantovani P. (1993) Calcium antagonist and antiperoxidant properties of some hindered phenols. Br. J. Pharmacol. 110, 369-77.
155. Shariff A. and Luna E. J. (1992) Diacylglycerol-stimulated formation of actin nucleation sites at plasma membranes. Science 256, 245-247.
156. Sharma R. V. and Bhalla R. C. (1993) PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells. Am. J. Physiol. 264, C71-9.
157. Shekhonin B. V., Tararak E. M., Samokhin G. P., Mitkevich O. V., Mazurov A. V., Vinogradov D. V., Vlasik T. N., Kalantarov G. F. and Koteliansky V. E. (1990) Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis. Atherosclerosis 82, 213-226.
158. Shimokado K., Raines E. W., Madtes D. K., Barrett T. B., Benditt E. P. and Ross R. (1985) A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 43, 277-286.
159. Shimokado K., Umezawa K. and Ogata J. (1995) Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle. Exp. Cell Res. 220, 266-273.
160. Singer R. H. (1992) The cytoskeleton and mRNA localization. Curr. Opin. Cell Biol. 4, 15-19.
161. Sjolund M., Hedin U., Sejersen T., Heldin C. H. and Thyberg J. (1988) Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype-and growth state-dependent manner. J. Cell Biol. 106, 403-413.
162. Sjolund M., Rahm M., Claesson Welsh E., Sejersen T., Heldin C. H. and Thyberg J. (1990) Expression of PDGF alpha-and beta-receptors in rat arterial smooth muscle cells is phenotype and growth state dependent. Growth Factors 3, 191-203.
163. Smith E. and Bingham-Smith J. (1994) Regulation of sodium calcium exchanger by glucocorticoids and growth factors in vascular smooth muscle. J. Biol. Chem. 269, 27527-27531.
164. Sorkin A., Eriksson A., Heldin C. H., Westermark B. and Claesson Welsh L. (1993) Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization. J. Cell Physiol. 156, 373-382.
165. Soyombo A. A., Thurston V. J. and Newby A. C. (1995) Endothelial control of vascular smooth muscle proliferation in an organ culture of human saphenous vein. Eur. Heart J. 14 Suppl I, 201-206.
166. Stenman G., Rorsman F. and Betsholtz C. (1988) Sublocalization of the human PDGF A-chain gene to chromosome 7, band q11.23, by in situ hybridization. Exp. Cell Res. 178, 180-184.
167. Sterpetti A. V., Cucina A., Fragale A., Lepidi S., Cavallaro A. and Santoro D. (1994) Shear stress influences the release of platelet derived growth factor and basic fibroblast growth factor by arterial smooth muscle cells. Winner of the ESVS prize for best experimental paper 1993. Eur. J. Vasc. Surg. 8, 138-142.
168. Stiko Rahm A., Hultgardh Nilsson A., Regnstrom J., Hamsten A. and Nilsson J. (1992) Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12, 1099-1109.
169. Stossel T. P. (1993) On the crawling of animal cells. Science 260, 1086-1094.
170. Stouffer G. A., Sarembock I. J., McNamara C. A., Gimple L. W. and Owens G. K. (1993a) Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am. J. Physiol. 265, C806-11.
171. Stouffer G. A., Shimizu R. T., Turla M. B. and Owens G. K. (1993b) ANG II-or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. Am. J. Physiol. 264, C390-5.
172. Stouffer G. A. and Owens G. K. (1994) TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J. Clin. Invest. 93, 2048-2055.
173. Stull J. T., Gallagher P. J., Herring B. P. and Kramm K. E. (1991) Vascular smooth muscle contractile elements. Cellular regulation. Hypertension 17, 723-732.
174. Sun P. D. and Davies D. R. (1995) The cysteine-knot growth factor superfamily. Annu. Rev. Biophys. Biomol. Struct. 24, 269-291.
175. Thyberg J. and Palmberg E. (1987) The calcium antagonist nisoldipine and the calmodulin antagonist W-7 synergistically inhibit initiation of DNA synthesis in cultured arterial smooth muscle cells. Biol. Cell 60, 125-132.
176. Valius M. and Kazlauskas A. (1993) Phospholipase C-γ1 and phosphatidylinositol 3 kinase are downstream mediators of the PDGF receptors mitogenic signal. Cell 73, 321-334.
177. Vojtek A. B. and Cooper J. A. (1995) Rho family members: activators of MAP kinase cascades. Cell 82, 527-529.
178. Walker L. N., Bowen Pope D. F., Ross R. and Reidy M. A. (1986) Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc. Natl. Acad. Sci. U.S.A. 83, 7311-7315.
179. Waterfield M. D., Scrace G. T., Whittle N., Stroobant P., Johnsson A., Wasteson A., Westermark B., Heldin C. H., Huang J. S. and Deuel T. F. (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304, 35-39.
180. Weksler B. B. (1987) Regulation of prostaglandin synthesis in human vascular cells. Ann. N. Y. Acad. Sci. 509, 142-148.
181. Wijetunge S. and Hughes A. D. (1995) Effect of platelet-derived growth factor on voltage-operated calcium channels in isolated rabbit ear artery cells. Br. J. Pharmacol. 115, 534-538.
182. Wilcox J. N., Smith K. M., Williams L. T., Schwartz S. M. and Gordon D. (1988) Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. Clin. Invest. 82, 1134-1143.
183. Williams L. T. (1989) Signal transduction by platelet-derived growth factor receptor. Science 243, 1564-1570.
184. Wilson E., Mai Q., Sudhir K., Weiss R. H. and Ives H. E. (1993) Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J. Cell Biol. 123, 741-747.
185. Winkles J. A. and Gay C. G. (1991) Regulated expression of PDGF A-chain mRNA in human saphenous vein smooth muscle cells. Biochem. Biophys. Res. Commun. 180, 519-524.
186. Yamaguchi M., Diamond S., Watanabe H., Gallati H., Baur W. and Sharefkin J. B. (1993) Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells. In Vitro Cell Dev. Biol. Anim. 29A, 867-872.
187. Yanagi H., Sasaguri Y., Sugama K., Morimatsu M. and Nagase H. (1991) Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis 91, 207-216.
188. Yarden Y., Escobedo J. A., Kuang W. J., Yang Feng T. L., Daniel T. O., Tremble P. M., Chen E. Y., Ando M. E., Harkins R. N., Francke U. et al. (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323, 226-232.
189. Zwijsen R. M., Japenga S. C., Heijen A. M., van den Bos R. C. and Koeman J. H. (1992) Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 186, 1410-1416.